The molecular profile of luminal B breast cancer
Chad J CreightonDepartment of Medicine and Dan L Duncan Cancer Center Division of Biostatistics. Baylor College of Medicine, Houston, TX, USAAbstract: Molecular profiling studies have found that estrogen receptor-positive (ER+) human breast cancers are comprised of at least two distinct diseases wit...
Saved in:
| Main Author: | Creighton CJ |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2012
|
| Subjects: | |
| Online Access: | https://doaj.org/article/bd5bf0ea2a234ec5ad9c19ddc12dd19d |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
by: Chenxuan Yang, et al.
Published: (2021) -
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
by: Zhu YY, et al.
Published: (2018) -
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
by: Sun JZ, et al.
Published: (2014) -
Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
by: Toshiaki Utsumi, et al.
Published: (2021) -
Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer
by: Balasundaram G, et al.
Published: (2015)